MSL

Welcome to the Brand page for “MSL”, which is offered here for Pharmaceutical preparations of monosodium luminol for treatment of metabolic distress, inflammatory conditions, infectious conditions, neurological disorders, proliferation diseases, cellular senescence, protein conformational diseases and use as an iron chelator and a proteostasis regulator;.

Its status is currently believed to be active. Its class is unavailable. “MSL” is believed to be currently owned by “Bach Pharma, Inc.”